Back

Watch Compare

PURPLE BIOTECH LTD.

Data quality: 33%

PPBT

Nasdaq Manufacturing Chemicals

$3.97

▼ $0.27 (-6.29%)

Mkt Cap: 6.06 M

Price

$3.97

Mkt Cap

6.06 M

Day Range

$3.96 — $4.28

52-Week Range

$3.60 — $29.40

Volume

14,223

Open $4.16

50D / 200D Avg

$4.97

20.26% below

50D / 200D Avg

$10.70

62.95% below

Quick Summary

Key Takeaways

P/E of 0.34 — trading at a low valuation

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

N/A

ROICN/A

Net MarginN/A

Op. MarginN/A

Safety

Debt / Equity

N/A

Current RatioN/A

Interest CoverageN/A

Valuation

PE (TTM)

0.34

Above sector avg (-1.48)

P/B RatioN/A

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	0.3	-1.5
P/B	—	1.6
ROE %	—	-53.4
Net Margin %	—	-41.5
Rev Growth 5Y %	—	1.8
D/E	—	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	N/A	Net Income (TTM)	17.83 M
ROE	N/A	ROA	N/A
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	N/A
ROIC	N/A	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	N/A
Interest Coverage	N/A	Asset Turnover	N/A
Working Capital	N/A	Tangible Book Value	N/A
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	0.34	Forward P/E	N/A
P/B Ratio	N/A	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	N/A
Market Cap	6.06 M	Enterprise Value	N/A
Per Share
EPS (Diluted TTM)	N/A	Revenue / Share	N/A
FCF / Share	N/A	OCF / Share	N/A
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	N/A
SBC-Adj. FCF	N/A	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2021
Revenue	—
Net Income	17.83 M
EPS (Diluted)	—
Gross Profit	—
Operating Income	—
EBITDA	—
R&D Expenses	—
SG&A Expenses	6.11 M
D&A	—
Interest Expense	—
Income Tax	—